IRIS
CAPONE, EMILY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.471
AS - Asia 1.244
EU - Europa 1.219
Continente sconosciuto - Info sul continente non disponibili 187
SA - Sud America 183
AF - Africa 38
OC - Oceania 1
Totale 5.343
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.372
SG - Singapore 600
IT - Italia 438
CN - Cina 248
VN - Vietnam 159
IE - Irlanda 158
BR - Brasile 148
RU - Federazione Russa 133
SE - Svezia 96
DE - Germania 86
IN - India 56
GB - Regno Unito 54
FR - Francia 49
CA - Canada 47
FI - Finlandia 46
TR - Turchia 41
UA - Ucraina 38
BD - Bangladesh 34
NL - Olanda 23
HK - Hong Kong 21
ZA - Sudafrica 17
AR - Argentina 15
PL - Polonia 15
LT - Lituania 14
AT - Austria 13
BE - Belgio 13
MX - Messico 11
IQ - Iraq 10
AE - Emirati Arabi Uniti 9
ES - Italia 9
JP - Giappone 9
KR - Corea 8
CH - Svizzera 7
EG - Egitto 7
CR - Costa Rica 6
EC - Ecuador 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
GR - Grecia 5
IL - Israele 5
JM - Giamaica 5
NI - Nicaragua 5
PK - Pakistan 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
GT - Guatemala 4
JO - Giordania 4
BB - Barbados 3
DK - Danimarca 3
EE - Estonia 3
HN - Honduras 3
HR - Croazia 3
ID - Indonesia 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
GP - Guadalupe 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SC - Seychelles 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
CL - Cile 1
CO - Colombia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 5.159
Salva come PNG Salva come JPEG
Città #
Singapore 439
San Jose 282
Chandler 207
Ashburn 159
Dublin 156
The Dalles 82
Council Bluffs 77
Beijing 75
Dallas 75
Santa Clara 75
Jacksonville 71
Los Angeles 61
New York 59
Pescara 56
Princeton 53
Chieti 50
Ho Chi Minh City 45
Ann Arbor 43
Buffalo 37
Munich 35
North Bergen 34
Boardman 29
Altamura 27
Hanoi 27
Phoenix 24
Dong Ket 22
Rome 22
Dearborn 20
Columbus 19
Hong Kong 18
Izmir 18
Milan 18
Nanjing 18
Wilmington 18
Lappeenranta 17
Montreal 17
Atlanta 16
Denver 16
Hefei 15
Houston 15
Tongling 15
Frankfurt am Main 14
Turku 14
Brussels 13
Brooklyn 12
Johannesburg 12
Moscow 12
Stockholm 12
Warsaw 12
L’Aquila 11
Nuremberg 11
Orem 11
Redondo Beach 11
São Paulo 11
Chennai 9
Da Nang 9
Helsinki 9
Pune 9
Southend 8
Tokyo 8
Vilnius 8
Washington 8
Cambridge 7
Cleveland 7
Falls Church 7
Haiphong 7
Hebei 7
London 7
Mumbai 7
Poplar 7
Rio de Janeiro 7
Seoul 7
Chicago 6
Dubai 6
Seattle 6
St Louis 6
Tashkent 6
Vienna 6
Cairo 5
Finale Ligure 5
Macerata 5
Managua 5
Nanchang 5
Ninh Bình 5
Norwalk 5
Perugia 5
Salvador 5
San José 5
Shanghai 5
Toronto 5
Vancouver 5
Zurich 5
Agrolândia 4
Amman 4
Baghdad 4
Belo Horizonte 4
Bologna 4
Castignano 4
Charlotte 4
Collecorvino 4
Totale 2.994
Salva come PNG Salva come JPEG
Nome #
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 250
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 239
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 199
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 189
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 187
ABCC3 is a novel target for the treatment of pancreatic cancer 179
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 171
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 166
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 166
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 163
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 162
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 157
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 146
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 146
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 145
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 144
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 140
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 139
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 137
Normal breathing releases SARS-CoV-2 into the air 132
Antibody-drug conjugates: The new frontier of chemotherapy 129
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 127
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 125
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 122
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 121
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 121
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 119
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 115
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 108
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 107
Endosialin-binding antibody 107
HER-3: Hub for escape mechanisms 103
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 94
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 92
MYC regulates metabolism through vesicular transfer of glycolytic kinases 92
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 84
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 82
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 75
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 53
LGALS3BP is associated with selective cargo enrichment in neuroblastoma extracellular vesicles 10
Totale 5.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022137 0 0 0 0 16 11 11 12 17 8 14 48
2022/2023539 43 97 35 65 46 86 20 45 64 12 18 8
2023/2024343 18 10 41 17 18 111 49 12 0 14 11 42
2024/20251.022 34 180 162 53 21 39 42 48 128 69 152 94
2025/20261.964 154 70 138 218 228 131 382 97 180 206 107 53
2026/2027733 56 214 123 229 111 0 0 0 0 0 0 0
Totale 5.343